RU 486 (Mifepristone) - A short overview of its mechanisms of action and clinical uses at the end of 1996

被引：55

作者：

Baulieu, EE

机构：

来源：

UTERUS: ENDOMETRIUM AND MYOMETRIUM | 1997年 / 828卷

关键词：

D O I：

10.1111/j.1749-6632.1997.tb48523.x

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

引用

页码：47 / 58

页数：12

共 16 条

[1]

AUBENY E, 1991, CR ACAD SCI III-VIE, V312, P539

[2]

Baulieu E E, 1975, Eur J Obstet Gynecol Reprod Biol, V4, P161, DOI 10.1016/0028-2243(75)90021-0

[3] CONTRAGESTION AND OTHER CLINICAL-APPLICATIONS OF RU-486, AN ANTIPROGESTERONE AT THE RECEPTOR [J].

BAULIEU, EE .

SCIENCE, 1989, 245 (4924) :1351-1357

[4]

Baulieu EE., 1985, ANTIPROGESTIN STEROI

[5] PROGESTERONE-RECEPTOR BLOCKAGE - EFFECT ON UTERINE CONTRACTILITY AND EARLY-PREGNANCY [J].

BYGDEMAN, M ;

SWAHN, ML .

CONTRACEPTION, 1985, 32 (01) :45-51

[6]

Cadepond F, 1997, ANNU REV MED, V48, P129

[7]

DONALDSON MS, 1993, CLIN APPL MIFEPRISTO

[8] SWITCHING AGONISTIC, ANTAGONISTIC, AND MIXED TRANSCRIPTIONAL RESPONSES TO 11-BETA-SUBSTITUTED PROGESTINS BY MUTATION OF THE PROGESTERONE-RECEPTOR [J].

GARCIA, T ;

BENHAMOU, B ;

GOFFLO, D ;

VERGEZAC, A ;

PHILIBERT, D ;

CHAMBON, P ;

GRONEMEYER, H .

MOLECULAR ENDOCRINOLOGY, 1992, 6 (12) :2071-2078

[9] TREATMENT OF UNRESECTABLE MENINGIOMAS WITH THE ANTIPROGESTERONE AGENT MIFEPRISTONE [J].

GRUNBERG, SM ;

WEISS, MH ;

SPITZ, IM ;

AHMADI, J ;

SADUN, A ;

RUSSELL, CA ;

LUCCI, L ;

STEVENSON, LL .

JOURNAL OF NEUROSURGERY, 1991, 74 (06) :861-866

[10]

HERRMANN W, 1982, CR ACAD SCI III-VIE, V294, P933

← 1 2 →